I agree Dave...offerings in biotech are usually placed after good news...so maybe they know something us retail investors don't know.
Darren is like the kid in a candy store with Karen being the responsible parent. I would be very afraid if Karen were to leave this company.
never mind I thought it was .38c but now I see it was .41c...so who do you suspect is doing all the selling?
Highlights: 4% increase in gross profit, 13% decrease in operating expenses, and reduction of operating loss YOY by $4.9M. only drawback was her admission of working capital being tight.
My thoughts on MCZ probably will not be popular on this board but there are still risks involved with MCZ and you may still get the opportunity to add in the .30c range. Earnings are coming up and let's face it they probably will not be good. Launch could be delayed or they may need more money and blindside us with another pipe like offering. Macro factors could also come into play as Greece or some other circumstance brings all stocks down. With that being said MCZ is still one of my largest positions and doesn't hurt to initiate a position here cause one never knows when market forces will bring the share price up. Good Luck
no expertise in the industry on my part MCT. I do not own the stock but put it in the contest because some 1st Q revenues are suppose to be pushed out to 2nd Q. May lead to a earnings surprise and like you posted DRWI is "interesting on a book value basis."
Nobody is worried about the 5T shares the VP sold. Surprised for the selloff today as I thought it would be tomorrow. 10% correction is probably good for the stock to shake out stop losses. Tommorrow will be interesting...
Forget the buyout... thanks domingodchilli for pointing out Investorday on June 17 and the positive news that may be coming out of it along with the initiation and price target of $30 is reason enough for the bump up.
Go figure, "Particle" is laying at a Minnesota festival soon...thanks for the heads up.